Outcome of fetal cardiac defects

Current Opinion in Pediatrics

Volumn 18, Issue 5, 2006, Pages 490-496

  Cuneo, Bettina F ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b ADVOCATE CHILDREN S HOSPITAL   (United States)

Author keywords

Arrhythmia; Congenital heart disease; Fetus; Outcomes

Indexed keywords

AMIODARONE; ANTIBODY; DEXAMETHASONE; DIGOXIN; FLECAINIDE; PROCAINAMIDE; SOTALOL; STEROID; TERBUTALINE; VERAPAMIL;

ADRENAL DISEASE; AORTA COARCTATION; ATRIOVENTRICULAR BLOCK; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DRUG EFFECT; EBSTEIN ANOMALY; FETUS HEART; FETUS HEART RATE; FETUS HYDROPS; GESTATIONAL AGE; GREAT VESSELS TRANSPOSITION; GROWTH RETARDATION; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART DISEASE; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INTRAUTERINE GROWTH RETARDATION; MORTALITY; NONHUMAN; OLIGOHYDRAMNIOS; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; TREATMENT DURATION; TREATMENT OUTCOME;

ARRHYTHMIAS, CARDIAC; FETAL DISEASES; HEART DEFECTS, CONGENITAL; HEART DISEASES; HUMANS; INFANT, NEWBORN;

EID: 33748756504     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000245348.52960.11     Document Type: Review

References (72)

1. Cuneo B, Strasburger J. Management strategy for fetal tachycardia. Obstetr Gynecol 2000; 96:575-581.
2. Krapp M, Kohl T, Simpson JM, et al. Review of diagnosis, treatment and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 2003; 89:913-917.
3. Simpson JM, Sharland GK. Fetal tachycardia: management and outcome of 127 consecutive cases. Heart 1998; 79:576-581.
4. Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 2000; 101:2721-2726.
5. Strasburger J, Cuneo B, Michon M, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 2004; 109:375-379. Largest case series using amiodarone in the sickest fetuses with supraventricular tachycardia, with minimal side effects and no mortality.
6. Lisowski LA, Veerheiijen PM, Benatar AA, et al. Atrial flutter in the perinatal age group: diagnosis, management and outcome. J Am Coll Cardiol 2000; 35:771-777.
7. Jaeggi E, Fouron JC, Drblik SP. Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 1998; 1322:335-339.
8. Krapp M, Baschat AA, Gembruch U, et al. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002; 19:158-164.
9. Jouuannic J-M, Dellahaye SS, Fermont L, et al. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy. Prenat Diagn 2003; 23:152-156.
10. Allan LD, Chita SK, Sharland GK, et al. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991; 65:46-48.
11. Parilla BV, Strasburger JF, Socol ML. Fetal supraventricular tachycardia complicated by hydrops fatalis: a role for direct fetal intramuscular therapy. Am J Perinatol 1996; 13:483-486.
12. Pielet BW, Socol ML, MacGregor SN, et al. Cordocentesis: an appraisal of risks. Am J Obstet Gynecol 1988; 159:1497-1500.
13. Flack NJ, Zosmer N, Bennett PR, et al. Amiodarone given by three routes to terminate fetal atrial flutter associated with severe hydrops. Am J Obstet Gynecol 1993; 82:714-716.
14. Copel JA, Buyon JP, Kleinman CS. Successful in utero therapy of fetal heart block. Am J Obset Gyneocol 1995; 173:1384-1390.
15. Raboisson MJ, Fouron JL, Sonnesson SE, et al. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies. J Am Soc Echocardiogr 2005; 18:375-380. Nicely details Doppler findings of first-degree atrioventricular block and its successful treatment with dexamethasone.
16. Saleeb S, Copel J, Friedman D, et al. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42:2335-2345.
17. Maeno Y, Himeno W, Saito A, et al. Clinical course of fetal congenital atrioventricular black in the Japanese population: a multicentre experience. Heart 2005; 91:1075-1079. A large retrospective series in which not all mothers were treated with dexamethasone.
18. Jaeggi ET, Fouron JC, Silverman ED, et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004; 110:1542-1548. The most convincing article supporting the use of transplacental dexamethasone not to prevent progression of atrioventricular block, but to improve intrauterine survival and possibly late-onset cardiomyopathy.
19. Berg C, Geipel A, Kohl T, et al. Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 2005; 26:4-15. Another large series associating poor outcome with structural cardiac defects.
20. Eronen M, Siren MK, Ekblad H, et al. Short and long term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000; 106:86-91.
21. Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from national neonatal lupus registry. J Am Coll Cardiol 1998; 31:1658-1666.
22. Groves AM, Allan LD, Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 1995; 92:3394-3396.
23. Nield LE, Silverman ED, Taylor GP, et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 2002; 105:843-848.
24. Moak JP, Barron KS, Hougen TJ, et al. Congenital heart block: development of late-onset cardiomyopathy: a previously under appreciated sequela. J Am Coll Cardiol 2001; 37:238-242.
25. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003; 62:1010-1012.
26. Burlet G, Fernette B, Blanchard S, et al. Antenatal glucocorticoids blunt the functioning of the hypothalamic-pituitary-adrenal axis of neonates and disturb some behaviors in juveniles. Neuroscience 2005; 133:221-230.
27. Coe CL, Lubach GR. Developmental consequences of antenatal dexamethasone treatment in nonhuman primates. Neurosci Biobehav Rev 2005; 29:227-235.
28. Cuneo B, Ambrose S, Duvall J, et al. Outcome of 616 fetuses with sustained arrhythmia or structural cardiac defect. Am J Obstet Gynecol 2005; 193:S134.
29. Robinson BV, Ettedgui JA, Sherman FS. Use of terbutaline in the treatment of complete heart block in the fetus. Cardiol Young 2001; 11:683-686.
30. Yoshida H, Iwamoto M, Sakakibara H, et al. Treatment of fetal congenital complete heart block with maternal administration of beta-sympathomimetics (terbutaline). Gynecol Obstet Invest 2001; 52:142-144.
31. Cuneo BF, Huhta JC. Ventricular and atrial response to terbutaline differs between left atrial isomerism and immune-mediated fetal complete AV block. Circulation 2004; 110:495(A).
32. Friedberg MK, Ursell PL, Silverman NH. Isomerism of the left atrial appendage associated with ventricular noncompaction. Am J Cardiol 2005; 96:985-990. Nice correlation of pathologic changes that may partially explain the poor outcome of this group of fetuses and infants.
33. Schmidt KG, Ulmer HE, Silverman NH, et al. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991; 17:1360-1366.
34. Berg C, Geipel A, Kamil D, et al. The syndrome of left isomerism: sonographic findings and outcome in prenatally diagnosed cases. J Ultrasound Med 2005; 24:921-931.
35. Jaeggi ET, Hornberger LK, Smallhorn JF, et al. Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol 2005; 26:16-21. A comprehensive and sobering review of outcomes of fetuses with atrioventricular block secondary to malformation of the conduction system.
36. Machado MVL, Tynan MJ, Curry PVL, et al. Fetal complete heart block. Br Heart J 1988; 60:512-515.
37. Khoshnood B, De Vigan C, Vodovar V, et al. Trends in prenatal diagnosis, termination and perinatal mortality of newborns with congenital heart disease in France 1983-2000: a population-based evaluation. Pediatrics 2005; 115:95-101. A large series detailing secular trends of the outcome of cardiac defects.
38. Mohan UR, Kleinman CS, Kern JH. Fetal echocardiography and its evolving impact 1992-2002. Am J Cardiol 2005; 96:134-136. A short concise article summarizing the tremendous effect of prenatal diagnosis in one cardiac center of excellence.
39. Allan LD, Sharland GK, Milburn A, et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 1994; 23:1452-1458.
40. Verheijen PM, Lisowski LA, Stoutenbeek P, et al. Lactacidosis in the neonate is minimized by prenatal detection of congenital heart disease. Ultrasound Obstet Gynecol 2002; 19:552-555.
41. Eapen RS, Rowland DG, Franklin WH. Effect of prenatal diagnosis of critical left heart obstruction on perinatal morbidity and mortality. Am J Perinatol 1998; 15:237-242.
42. Kumar RK, Newburger JW, Gauvreau K, et al. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol 1999; 83:1649-1653.
43. Brick DH, Allan LD. Outcome of prenatally diagnosed congenital heart disease: an update. Pediatr Cardiol 2002; 23:449-453.
44. Boldt T, Andersson S, Eronen M. Outcome of structural heart disease diagnosed in utero. Scand Cardiovasc J 2002; 36:73-79.
45. Perolo A, Prandstraller D, Ghi T, et al. Diagnosis and management of fetal cardiac anomalies: 10 years of experience at a single institution. Ultrasound Obstet Gynecol 2001; 18:615-618.
46. Cedergren MI, Kallen BA. Obstetric outcome of 6346 pregnancies with infants affected by congenital heart defects. Eur J Obstet Gynecol Reprod Biol 2006; 125:211-216.
47. Yates RS. The influence of prenatal diagnosis on postnatal outcome in patients with structural congenital heart disease. Prenat Diagn 2004; 24:1143-1149. A complete review raising questions about the definition of 'good outcome'.
48. Sullivan ID. Prenatal diagnosis of structural heart disease: does it make a difference to survival? Heart 2002; 87:405-406.
49. Andrews RE, Simpson JM, Sharland GK, et al. Outcome after preterm delivery of infants antenatal diagnosed with congenital heart disease. J Pediatrics 2006; 148:213-216.
50. Berg C, Geipel A, Smrcek J, et al. Prenatal diagnosis of cardiosplenic syndromes: a 10-year experience. Ultrasound Obstet Gynecol 2003; 22:451-459.
51. Taketazu M, Lougheed J, Yoo S-J, et al. Spectrum of cardiovascular disease, accuracy of diagnosis and outcome in fetal heterotaxy syndrome. Am J Cardiol 2006; 97:720-724. A nice review of a fairly uncommon series of cardiac defects.
52. Lim JS, McCrindle BW, Smallhorn JE, et al. Clinical features, management, and outcome of children with fetal and postnatal diagnoses of isomerism syndromes. Circulation 2005; 112:2454-2461.
53. Volpe P, Paladini D, Marasini M, et al. Common arterial trunk in the fetus: characteristics, associations, and outcome in a multicentre series of 23 cases. Heart 2003; 89:1437-1441.
54. Duke C, Sharland GK, Jones AM, Simpson JM. Echocardiographic features and outcome of truncus arteriosus diagnosed during fetal life. Am J Cardiol 2001; 88:1379-1384.
55. McElhinney DB, Salvin JW, Colan SD, et al. Improving outcomes in fetuses and neonates with congenital displacement (Ebstein's Malformation) or dysplasia of the tricuspid valve. Am J Cardiol 2005; 96:582-586. This manuscript is helpful to the perinatal cardiologist in counseling families with fetal tricuspid valve disease.
56. Verheijen PM, Lisowski LA, Stoutenbeck P, et al. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Thorac Cardiovasc Surg 2001; 121:798-803.
57. Tworetzky W, McElhinney DB, Reddy VM, et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001; 103:1269-1273.
58. Fountain-Dommer RR, Bradley SM, Atz AM, et al. Outcome following, and impact of, prenatal identification of the candidates for the Norwood procedure. Cardiol Young 2004; 14:32-38.
59. Allen RH, Benson CB, Haug LW. Pregnancy outcome of fetuses with a diagnosis of hypoplastic left ventricle on prenatal sonography. J Ultrasound Med 2005; 24:1199-1203.
60. Mahle WT, Claney RR, McGaurn SP, et al. Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome. Pediatrics 2001; 107:277-282.
61. Jouannic JM, Gavard L, Fermont L, et al. Sensitivity and specificity of prenatal features of physiological shunts to predict neonatal clinical status in transposition of the great arteries. Circulation 2004; 110:1743-1746.
62. Bonnet D, Coltri A, Butera G, et al. Prenatal diagnosis of transposition of great vessels reduces neonatal morbidity and mortality. Arch Mal Coer Vaiss 1999; 92:637-640.
63. Bartlett JM, Wypij D, Bellinger DC, et al. Effect of prenatal diagnosis on outcomes in D-Transposition of the great arteries. Pediatrics 2004; 113:335-340.
64. Franklin O, Burch M, Manning N, et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002; 87:67-69.
65. Paladini D, Volpe P, Marasini M. Diagnosis, characterization and outcome of congenitally corrected transposition of the great arteries in the fetus: a multicenter series of 30 cases. Ultrasound Obstet Gynecol 2006; 27:281-285.
66. Tworetzky W, Wilkins-Haug L, Jennings RW, et al. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation 2004; 110:2125-2131.
67. Makikalliok K, McElhinney DB, Lveine JC, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation 2006; 113:1401-1405. With more experience, candidate selection and timing of in-utero intervention may result in more biventricular repairs. The Boston group has the most experience, and this is a nice summary of their philosophy.
68. Tulzer G, Arzt W, Franklin RC, et al. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet 2002; 360:1567-1568.
69. Marshall AC, Van der Velde ME, Tworetzky W, et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation 2004; 110:253-258.
70. Donofrio MT, Bremer YA, Moskowitz WB. Diagnosis and management of restricted or closed foramen ovale in fetuses with congenital heart disease. Am J Cardiol 2004; 94:1348-1351.
71. Vlahos AP, Lock JE, McElhinney DB, Van der Velde ME. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation 2004; 109:2326-2330.
72. Javois AJ, Van Bergen AH, Cuneo BF, et al. Novel approach to the newborn with hypoplastic left heart syndrome and intact atrial septum. Catheterization Cardiovasc Interventions 2005; 66:268-272. Unique and successful management of a potentially lethal cardiac defect.